Literature DB >> 8255379

[Surgical decompression for the C-1 and C-2 sensory roots and upper cervical cord in a case with cervical myelopathy and occipital neuralgia due to bilateral fenestration of vertebral artery: a case report].

K Morikawa1, N Ohkawa, S Yamashita.   

Abstract

A case of bilateral fenestration of the vertebral artery at the level of the atlas in a patient who had occipital neuralgia and cervical myelopathy is presented. MRI and vertebral angiogram demonstrated the fenestrated vertebral artery compressing the upper cervical cord. Surgical decompression for the C-1 and C-2 sensory roots and the upper cervical cord was performed. Fenestration of the vertebral artery is mostly of no clinical significance. However, considering the pathway of the fenestrated vertebral artery, it is quite possible that the fenestrated vertebral artery might compress the neural structures, resulting in some clinical problems. Although occipital neuralgia may result from a variety of causes, this case was caused by the fenestrated vertebral artery compressing the C-1 and C-2 sensory roots. The authors wish to emphasize that microsurgical vascular decompression may be the only effective treatment in such cases as well as in facial spasm and trigeminal neuralgia.

Entities:  

Mesh:

Year:  1993        PMID: 8255379

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  3 in total

1.  Anomalous vertebral artery compression of the spinal cord at the cervicomedullary junction.

Authors:  Bret Gene Ball; Bruce R Krueger; David G Piepgras
Journal:  Surg Neurol Int       Date:  2011-07-28

2.  Usefulness of Intraoperative Monitoring during Microsurgical Decompression of Cervicomedullary Compression Caused by an Anomalous Vertebral Artery.

Authors:  Sung Tae Kim; Sung Hwa Paeng; Dong Mun Jeong; Kun Soo Lee
Journal:  J Korean Neurosurg Soc       Date:  2014-12-31

3.  Cervical myelopathy due to neurovascular compression syndrome caused by persistent first intersegmental artery: a case report.

Authors:  Takuro Endo; Taku Sugawara; Naoki Higashiyama
Journal:  BMC Neurol       Date:  2020-11-03       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.